<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01343160</url>
  </required_header>
  <id_info>
    <org_study_id>VBR CS 156</org_study_id>
    <nct_id>NCT01343160</nct_id>
  </id_info>
  <brief_title>Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures</brief_title>
  <official_title>Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the
      endoscopic and percutaneous treatment of benign biliary strictures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary outcome measure is patency at each follow up visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful treatment of benign stricture upon implant</measure>
    <time_frame>Upon implant</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Biliary Strictures</condition>
  <arm_group>
    <arm_group_label>GORE VIABIL® Biliary Endoprosthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Placement of GORE VIABIL® Biliary Endoprosthesis to establish duct patency</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GORE® VIABIL® Biliary Endoprosthesis</intervention_name>
    <description>Deployment of GORE® VIABIL® Biliary Endoprosthesis to the area of stricture</description>
    <arm_group_label>GORE VIABIL® Biliary Endoprosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is diagnosed with treatable benign biliary stricture which necessitates the
             need for implantation of a biliary endoprosthesis

          -  Subject is ≥18 years of age

          -  Subject is able to comply with study protocol and follow-up requirements

          -  Written informed consent is obtained using the Investigational Review Board
             (IRB)/Ethics Committee (EC) approved consent form

        Exclusion Criteria:

          -  Subject anatomy ruling out covered self expanding metal stent use (e.g. above hilar
             region)

          -  Treatment of stricture would require placement of a covered biliary endoprosthesis
             within a previously placed bare metal stent

          -  The subject has malignant biliary disease

          -  Subject has known pregnancy

          -  Participated in protocol involving investigational drug or device within 90 days prior
             to entry into this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karel Caca, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Ludwigsburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2011</study_first_submitted>
  <study_first_submitted_qc>April 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2011</study_first_posted>
  <last_update_submitted>October 12, 2015</last_update_submitted>
  <last_update_submitted_qc>October 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

